375 results on '"Manara, Maria Cristina"'
Search Results
2. Correction: Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells
3. Supplementary Figure 5 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
4. Supplementary Figure 3 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
5. Data from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
6. Supplementary video 1 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
7. Supplementary Figure 9 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
8. Supplementary Figure 11 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
9. Supplementary Figure 4 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
10. Supplementary Figure 2 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
11. Supplementary Table S1 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
12. Supplementary video 2 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
13. Supplementary Figure 7 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
14. Supplementary Figure 6 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
15. Supplementary Figure 8 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
16. Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma
17. Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
18. IL-1 Family Members in Bone Sarcomas
19. Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
20. Circulating miR34a levels as a potential biomarker in the follow-up of Ewing sarcoma
21. Ewing Sarcoma PDX Models
22. Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma
23. ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity
24. Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells
25. Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99
26. CD99 at the crossroads of physiology and pathology
27. Data from A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy
28. Figure S1 from A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy
29. Supplementary Materials and Methods from A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy
30. Table S2 from A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy
31. Supplementary Figure S5 from Trabectedin Efficacy in Ewing Sarcoma Is Greatly Increased by Combination with Anti-IGF Signaling Agents
32. Fig.s3new from Trabectedin Overrides Osteosarcoma Differentiative Block and Reprograms the Tumor Immune Environment Enabling Effective Combination with Immune Checkpoint Inhibitors
33. Table S1 from Trabectedin Overrides Osteosarcoma Differentiative Block and Reprograms the Tumor Immune Environment Enabling Effective Combination with Immune Checkpoint Inhibitors
34. Table S2-S3-S4 from Trabectedin Overrides Osteosarcoma Differentiative Block and Reprograms the Tumor Immune Environment Enabling Effective Combination with Immune Checkpoint Inhibitors
35. Data from Trabectedin Overrides Osteosarcoma Differentiative Block and Reprograms the Tumor Immune Environment Enabling Effective Combination with Immune Checkpoint Inhibitors
36. Fig.S5 new from Trabectedin Overrides Osteosarcoma Differentiative Block and Reprograms the Tumor Immune Environment Enabling Effective Combination with Immune Checkpoint Inhibitors
37. Supplementary Methods from CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin
38. Supplementary Figure 5 from CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin
39. Supplementary Figure 4 from CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin
40. Supplementary Figure 1 from CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin
41. SupplementarydataREV from Trabectedin Overrides Osteosarcoma Differentiative Block and Reprograms the Tumor Immune Environment Enabling Effective Combination with Immune Checkpoint Inhibitors
42. Supplementary Figure 2 from CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin
43. Data from Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma
44. Supplementary Table 1 from Trabectedin Efficacy in Ewing Sarcoma Is Greatly Increased by Combination with Anti-IGF Signaling Agents
45. Supplementary Figure 3 from CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin
46. Supplementary Tables 1-6 from CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin
47. Supplementary Data from Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma
48. Supplementary Figure 6 from CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin
49. Supplementary Figure 1 from Caveolin-1 Reduces Osteosarcoma Metastases by Inhibiting c-Src Activity and Met Signaling
50. Supplementary Figure 2 from Caveolin-1 Reduces Osteosarcoma Metastases by Inhibiting c-Src Activity and Met Signaling
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.